Pharmacotherapy Publications, Inc. (PPI), ACCP’s corporate journal-publishing division, will begin publishing ACCP’s second official journal in October 2018.

The new journal, Journal of the American College of Clinical Pharmacy (JACCP), will publish papers across the spectrum of clinical pharmacy practice. JACCP will be online only and distributed to ACCP members with no increase in membership dues. Members will also continue to receive monthly issues of Pharmacotherapy, the Journal of Human Pharmacology and Drug Therapy.

Jerry L. Bauman, Pharm.D., FCCP, FACC, will serve as editor-in-chief of JACCP. Bauman is a dean and distinguished professor at the University of Illinois at Chicago (UIC) College of Pharmacy and a professor in the Department of Medicine, Section of Cardiology at UIC. Bauman’s area of research is the clinical pharmacology of cocaine and the drugs used to treat cardiac rhythm disorders. He has published extensively in these areas and received ACCP’s Russell R. Miller Award for Research in 1994 as a result. He was the first pharmacist with a Pharm.D. degree to be elected as a fellow in the American College of Cardiology. Bauman is a past president of ACCP and recently retired from more than a decade of service as a scientific editor for Pharmacotherapy.

Bauman has assembled a panel of scholars to assist him in the editorial office. Robert B. Parker, Pharm.D., FCCP; Beth Bryles Phillips, Pharm.D., FCCP, FASHP, BCPS, BCACP; and Alan J. Zillich, Pharm.D., FCCP, will serve as associate editors of JACCP.

JACCP will begin taking submissions in January 2018. The new journal will serve as a forum for discussions of clinical pharmacy practice research, education, and training. In addition, JACCP will publish official ACCP position and policy papers and Board of Pharmacy Specialties recertification modules.